MedTrace Logo

Circulating Tumor Cells and Melanoma: Comparing the EPISPOT and CellSearch Techniques

NCT01558349 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 73

Last updated 2025-11-19

No results posted yet for this study

Summary

The main objective of this study is to compare results for the detection of circulating melanoma cells (CMC) using CellSearch versus EPISPOT (EPithelial ImmunoSPOT) techniques between a group of patients with metastatic melanoma and a group of hospitalized control patients.

Conditions

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nīmes

    lead OTHER

Principal Investigators

  • Laurent Meunier, MD · Centre Hospitalier Universitaire de Nîmes

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-27
Primary Completion
2017-06-27
Completion
2017-06-27

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01558349 on ClinicalTrials.gov